Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 03/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | +2.40% | +65.70% | +121.34% | 55.35B | |
| +1.58% | +14.12% | +72.87% | +85.18% | 51.92B | |
| +0.22% | +0.36% | -14.72% | -15.35% | 22.76B | |
| +1.56% | +7.62% | +4.31% | +433.00% | 22.64B | |
| -0.18% | +7.48% | +32.16% | -14.07% | 17.36B | |
| -1.57% | +3.64% | +28.24% | -34.74% | 16.1B | |
| +3.02% | +12.74% | +143.33% | +308.04% | 13.96B | |
| +3.39% | +6.74% | +27.20% | +181.65% | 13.38B | |
| +1.31% | +6.52% | +28.62% | - | 12.27B | |
| Average | +1.22% | +5.82% | +43.08% | +133.13% | 25.08B | |
| Weighted average by Cap. | +1.24% | +6.54% | +48.33% | +124.24% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
